Pharmaceutical Science Update

Posted By Linda Brown
Found In Microsite: AAPS News Magazine
April 18, 2018 Companies developing products that combine a diagnostic test and a cancer drug would face less paperwork to get their clinical trials going under a Food and Drug Administration (FDA) policy proposal. The agency said it wants to streamline ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
April 18, 2018 Advanced genetic screening tests key to development of targeted treatments known as precision medicine will get Food and Drug Administration (FDA) scrutiny under new final agency guidance. The set of two guidance documents released on ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
April 18, 2018 China’s tax cut for generic drugmakers will be a boon for domestic companies, practitioners said.  On April 3, the State Council slashed China’s corporate tax rate to 15 percent from 25 percent for generic drugmakers that are deemed high-tech ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
April 18, 2018 Successfully creating a new pain medication without the addictive properties linked to opioids will require innovative research models, a public health professor told Bloomberg Law. “The development of non-addictive painkillers has been ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
April 11, 2018 Research institutions can avoid tighter federal reins on grants with better oversight and a culture of compliance, experts said in light of recent penalties administered to a top university. The National Institutes of Health (NIH) hit ...